Đang chuẩn bị liên kết để tải về tài liệu:
Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptortyrosine kinase inhibitors for non-small cell lung cancer

While epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) exert a breakthrough effect, the incidence of skin disorders as a side effect has significantly reduced patients’ quality of life. | Minocycline prevents and repairs the skin disorder associated with afatinib one of the epidermal growth factor receptortyrosine kinase inhibitors for non-small cell lung cancer